Found 5 matching trials
Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency
PHASE3CAEB1102-300A is a multi-center randomized, double-blind, placebo-controlle...
Location
Harvey Pediatrics
A Study of AEB1102 (Pegzilarginase) in Patients With Arginase I Deficiency
PHASE2The purpose of this study is to investigate the long-term safety, tolerabil...
Location
Stanford University School of Medicine
A Study of Safety of Weekly Subcutaneous Pegzilarginase in Subjects With Arginase 1 Deficiency
PHASE3This is an open-label, multicenter study to evaluate the safety of weekly S...
Location
Hospital for Sick Children
Pegzilarginase and Pembrolizumab for Extensive Disease Small Cell Lung Cancer
PHASE1The main purpose of this Phase 1/2 study is to determine the safety and eff...
Location
University of Alabama, Mitchell Cancer Institute
Pegzilarginase in Subjects <24 Months Old With Arginase 1 Deficiency
PHASE3This is an open-label, multicentre study to evaluate the safety, PK, and ac...
Location
Univ. Klinik für Kinder- und Jugendheilkunde Medizinische Universität